We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Technique Reduces Loss of MicroRNAs from Biological Specimens

By LabMedica International staff writers
Posted on 16 Feb 2009
A recent publication described the development of a technique for preventing microRNAs, small regulatory RNAs with many biological functions and disease associations, from leaking from biological specimens during fixation. More...


Usually biological specimens such as tissues or cells are treated with a cross linking agent such as formaldehyde to fix molecules in place. The agent locks the specimen's macromolecules into a type of minute scaffolding, but as explained by first author Dr. John Pena, assistant professor of molecular biology at the Rockefeller University (New York, NY, USA), "Because microRNAs are so small, they come out of the tissue. They just fall through the scaffold."

Dr. Pena and his colleagues reported in the January 11, 2009, online edition of the journal Nature Methods that the loss of microRNAs from formaldehyde-fixed tissues could be prevented by subsequent fixation with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). This treatment irreversibly immobilized the microRNA at its 5' phosphate end.

They tested this method on more than 130 microRNAs in an assortment of tissues including heart, liver, muscle, and brain. Results showed that retention of microRNAs by tissues treated with formaldehyde and EDC was consistently greater than in tissues treated with formaldehyde alone.

"If microRNAs are going to be used as a diagnostic tool, we need a reliable way to measure them in normal and disease tissue, regardless of where or to what degree they are expressed," said Dr. Pena. "So that is what we did: We went back and examined and questioned every single step of this protocol to see where we could optimize it. In order to move forward, we had to go to the basics."

Related Links:
Rockefeller University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.